Gamma Medica has begun marketing a cardiac gating subsystem for its preclinical imaging system. X-SPECT, the company's second-generation MicroSPECT system, is used by medical researchers and drug companies to visualize molecular markers in animal
Gamma Medica has begun marketing a cardiac gating subsystem for its preclinical imaging system. X-SPECT, the company's second-generation MicroSPECT system, is used by medical researchers and drug companies to visualize molecular markers in animal subjects. The gating subsystem freezes movement of the heart to allow more accurate in vivo cardiac imaging.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.